NCT06626178Recruiting
Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
ARtificial Intelligence for heAlth and Prevention of Smoking-related Diseases
Source: ClinicalTrials.gov · Last updated 3 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study is an interventional pilot study. The study is designed to be monocentric and it presents additional procedues.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 2840 (estimated)
- First submitted
- 1 Oct 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Scientific Institute San Raffaele
- Diseases
- Lung cancer
- NCT number
- NCT06626178
What you commit to
- Study type: Interventional
- Planned participants: 2840
- From 1 Oct 2024 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or concurrent neoplastic disease, excluding skin cancers
- Previous low-dose computed tomography (CT) scan in the past 12 months
- Previous high-risk positive screening subjects
- Previous high-risk negative screening subjects
- Previous neoadjuvant treatment
Other illness
- Severe pulmonary or extra pulmonary disease
- Lung Cancer patients
Other
- Cognitive or other problems that could hinder the collection of informed consent
- \- None
- \- None
- computed tomography (CT) scans not available at San Raffaele Hospital
Who the study is looking for
- Age \>= 50 years old
- Active smokers
- Former smokers (from no more than 15 years)
- Pack/year \>20
- Risk-prediction model from Prostate, Lung, Colorectal, and Ovarian study (PLCOm2012) \>1.2%
- Provision and signature of informed consent
- Subjects enrolled in previous lung cancer screening with the presence of lung nodules \>4 mm and candidate to additional computed tomography (CT)
- Signed informed consent
- Subjects enrolled in previous lung cancer screening in this Institute with negative computed tomography (CT)
- Signed informed consent
- Patients with diagnosis or suspicious diagnosis of lung cancer candidate to surgical treatment or already submitted to it
- Patients with diagnosis of lung cancer treated with surgical resection
- Signed informed consent
Criteria the registry did not label
- High-risk screening subjects
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Scientific Institute Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.